about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesLeishmania RNA virus: when the host pays the tollEssential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunitySpatiotemporal Regulation of Hsp90-Ligand Complex Leads to Immune ActivationImmunomodulatory functions of type I interferonsThe regulation of inflammation by interferons and their STATsPopulation genetics and human immunity: the interferon paradigmDifferential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infectionsRegulation of type I interferon responsesInterferon-alpha, immune activation and immune dysfunction in treated HIV infectionBiosynthesis and possible functions of inositol pyrophosphates in plantsThe STING pathway and the T cell-inflamed tumor microenvironmentOverlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functionsHost immune response to infection and cancer: unexpected commonalitiesCardiovascular disease in lupus: insights and updatesSignal transducer and activator of transcription 4 in liver diseasesImmune mechanisms in cerebral ischemic toleranceCrosstalk between Mycobacterium tuberculosis and the host cellTLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetesReverse translation in tuberculosis: neutrophils provide clues for understanding development of active diseaseHuman β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic AcidAn Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory PathogensSplenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for controlLeukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infectionsDeregulation of type I IFN-dependent genes correlates with increased susceptibility to cytomegalovirus acute infection of dicer mutant miceType I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous systemDampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replicationSexual dimorphism in autoimmunityBacterial recognition pathways that lead to inflammasome activationDisease-promoting effects of type I interferons in viral, bacterial, and coinfectionsA BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responsesType I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infectionsGeneration of mouse small intestinal epithelial cell lines that allow the analysis of specific innate immune functionsControl of bone formation by the serpentine receptor Frizzled-9Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunityIdentification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyMurine Cytomegalovirus Disrupts Splenic Dendritic Cell Subsets via Type I Interferon-Dependent and -Independent Mechanisms.Salmonella Suppresses the TRIF-Dependent Type I Interferon Response in Macrophages.The immune profile associated with acute allergic asthma accelerates clearance of influenza virusType I interferon receptor deficiency prevents murine Sjogren's syndrome
P2860
Q21131160-0701A4FE-A2A0-4FA4-9A6F-4F35BF237D4FQ21131306-F2C6AA25-5255-4B5D-B0FA-2FCBA54C25B3Q24312889-2C6A4DB3-7C8E-44A5-BB81-6744DC00D70EQ26744078-1A0B3F28-F114-4573-A810-5888D4330F1FQ26823904-A64EB030-D6DE-40B4-B53A-74549E1036B3Q26829387-6F76FA4B-62C2-4BA4-89FE-80D1AE036900Q26830286-BF4745CE-671A-45D6-94E6-4925F97B1AA2Q26849516-F94E3DEA-290B-4A82-8ABD-79BAB5549AB8Q26853177-5E066B0B-51D4-4443-BA54-C6505FB371F5Q26861003-175CC01B-07B8-4F40-A6C2-5B84BECE9A90Q27007488-8A680CF3-CF97-4322-BE32-5971E77563C2Q27008371-E9983A62-B065-44EC-9447-4BF3F4474852Q27014714-67F255C8-C877-4CF7-8C59-1D59C066ACF6Q27015410-93243BB6-CA90-4F28-9C76-027D1C165731Q27016554-9396DA07-0895-468E-B710-F6CAC4B82F8BQ27016571-2B43D01F-1BE2-42A9-A71A-B4BC45EA75F2Q27022067-20160E38-8725-4E04-BC09-7649754BCA14Q27022090-766F6F82-8814-4176-BCB7-11CF97006BEAQ27025559-7E491231-9686-4690-A8CC-E91D323C28A7Q27027976-65B7B8CA-D394-4CA0-BC94-F3B5C4848108Q27310039-B07D88DA-4F8D-4E2E-A958-29215B16AF7AQ27312333-259A8B72-3B39-4FB5-B2CB-60B1546A5E2EQ27312553-540301C5-3030-455A-87B8-E52D352FBC64Q27320523-3EA4E64E-828F-4FE4-B70B-21D580BD2D4CQ27322501-2D33EEAA-EA2F-4B1D-9B2C-05AD3FBB6212Q27334626-4B0CA6E3-56FF-419F-BFC0-45891BD59E68Q27869764-975DC63A-AA4E-4C0C-8F8E-674A29A9AF5CQ28080459-CF8A96F0-EE7E-4A69-9ED8-CC4845F49A6BQ28081450-6390A0AF-E5D1-48C0-8BCD-487F827D8D9CQ28082841-D9A50439-C05E-4A7B-AA25-5FC8ABC030ADQ28118033-CE05D3E8-0ECF-4D74-8B55-35C57F788187Q28481589-E9BDA7DF-AF40-43C3-AF80-555EEF6EA154Q28535135-711E3160-6B89-43C2-A004-0CE008B81A98Q28587080-43A79FD5-9C23-40B3-A296-65C991F1FA91Q28660378-094AB8B2-1159-41A2-92B4-0889B61C4417Q29417020-4AD94843-7366-4B9D-9754-CB0A1BBC01F1Q30252883-E25FA22C-C4E4-4E87-97F3-4A418F4AA905Q30277329-4FE73FAA-0062-4DA5-836F-A81224995FC0Q30358384-46D2B48E-F7C7-4CDF-B368-83B3DF2CA4F8Q30413385-13E3B673-0109-4328-8D9C-B4F7D6AF61E1
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Type I interferon: friend or foe?
@ast
Type I interferon: friend or foe?
@en
Type I interferon: friend or foe?
@nl
type
label
Type I interferon: friend or foe?
@ast
Type I interferon: friend or foe?
@en
Type I interferon: friend or foe?
@nl
prefLabel
Type I interferon: friend or foe?
@ast
Type I interferon: friend or foe?
@en
Type I interferon: friend or foe?
@nl
P2860
P3181
P356
P1476
Type I interferon: friend or foe?
@en
P2093
Giorgio Trinchieri
P2860
P304
P3181
P356
10.1084/JEM.20101664
P407
P577
2010-09-27T00:00:00Z